J. Paul Abernathy - 04 May 2023 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Role
Director
Signature
/s/ J. Paul Abernathy
Issuer symbol
NHC
Transactions as of
04 May 2023
Net transactions value
$0
Form type
4
Filing time
04 May 2023, 18:29:43 UTC
Previous filing
27 Feb 2023
Next filing
28 Aug 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NHC Shares of Common Stock 31,390 04 May 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHC Option to Purchase Common Stock [2023 Grant] Award $0 +7,500 $0.000000 7,500 04 May 2023 Common Stock 7,500 $55.75 Direct F1
holding NHC Option to Purchase Common Stock 5,895 04 May 2023 Common Stock 5,895 $77.92 Direct
holding NHC Option to Purchase Common Stock [2020 Grant] 7,500 04 May 2023 Common Stock 7,500 $64.64 Direct
holding NHC Option to Purchase Common Stock [2021 Grant] 7,500 04 May 2023 Common Stock 7,500 $71.64 Direct
holding NHC Option to Purchase Common Stock [2022 Grant] 7,500 04 May 2023 Common Stock 7,500 $69.19 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options were granted pursant to the 2020 Obmnibus Equity Incentive Plan on May 4, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).